about
Progressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and SilymarinGlucocorticoid deficiency increases phospholipase A2 activity in ratsCharacterization of major zinc containing myonecrotic and procoagulant metalloprotease 'malabarin' from non lethal trimeresurus malabaricus snake venom with thrombin like activity: its neutralization by chelating agents.Use of Pavo cristatus feather extract for the better management of snakebites: neutralization of inflammatory reactions.Malabarase, a serine protease with anticoagulant activity from Trimeresurus malabaricus venom.Identification of novel inhibitors of Daboia russelli phospholipase A2 using the combined pharmacophore modeling approach.PLA2 mediated arachidonate free radicals: PLA2 inhibition and neutralization of free radicals by anti-oxidants--a new role as anti-inflammatory molecule.Biochemical and biological characterization of Naja kaouthia venom from North-East India and its neutralization by polyvalent antivenom.Dimethyl ester of bilirubin exhibits anti-inflammatory activity through inhibition of secretory phospholipase A2, lipoxygenase and cyclooxygenase.Inhibitory potential of three zinc chelating agents against the proteolytic, hemorrhagic, and myotoxic activities of Echis carinatus venom.Local and systemic toxicity of Echis carinatus venom: neutralization by Cassia auriculata L. leaf methanol extract.Furosemide inhibits 11 beta-hydroxysteroid dehydrogenase in vitro and in vivo.Differences in phospholipase A2 activity between males and females and Asian Indians and Caucasians.Chemical modification of ascorbic acid and evaluation of its lipophilic derivatives as inhibitors of secretory phospholipase A(2) with anti-inflammatory activity.Interaction of plant lipids with 14 kDa phospholipase A2 enzymes.Radical scavenging and angiotensin converting enzyme inhibitory activities of standardized extracts of Ficus racemosa stem bark.Systemic pathological effects induced by cobra (Naja naja) venom from geographically distinct origins of Indian peninsula.Synthesis and evaluation of antioxidant and antibacterial activities of new substituted bis(1,3,4-oxadiazoles), 3,5-bis(substituted) pyrazoles and isoxazoles.Ascorbic acid 6-palmitate: a potent inhibitor of human and soybean lipoxygenase-dependent lipid peroxidation.Topical application of serine proteases from Wrightia tinctoria R. Br. (Apocyanaceae) latex augments healing of experimentally induced excision wound in mice.Synthesis of benzophenone oxime analogues as inhibitor of secretory phospholipase A(2) with anti-inflammatory activity.Effect of anticoagulants on the plasma hyaluronidase activities.Procoagulant activity of Calotropis gigantea latex associated with fibrin(ogen)olytic activity.Differential action of medically important Indian BIG FOUR snake venoms on rodent blood coagulation.Anti-tubercular and anti-inflammatory activities of azetidin-2-one derivatives and their effects on the activity of Phospholipase A2.Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.Purification and characterization of an anti-hemorrhagic protein from Naja naja (Indian cobra) venom.Hyaluronidase and protease activities from Indian snake venoms: neutralization by Mimosa pudica root extract.EC-PIII, a novel non-hemorrhagic procoagulant metalloproteinase: Purification and characterization from Indian Echis carinatus venom.Celastrol modulates inflammation through inhibition of the catalytic activity of mediators of arachidonic acid pathway: Secretory phospholipase A2 group IIA, 5-lipoxygenase and cyclooxygenase-2.Biochemical and pharmacological characterization of three toxic phospholipase A2s from Daboia russelii snake venom.Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity.Inhibition of secretory phospholipase A(2) enzyme by bilirubin: a new role as endogenous anti-inflammatory molecule.Neutralization of local toxicity induced by vipera russelli phospholipase A2 by lipophilic derivative of ascorbic acid.Albizia lebbeck seed methanolic extract as a complementary therapy to manage local toxicity of Echis carinatus venom in a murine model.Silymarin potentiates the anti-inflammatory effects of Celecoxib on chemically induced osteoarthritis in ratsPurification and partial biochemical characterization of an edema inducing phospholipase A2 from Vipera russelli (Russell's viper) snake venomAdrenalectomy decreases lipocortin-I messenger ribonucleic acid and tissue protein content in ratsInteraction of aristolochic acid with Vipera russelli phospholipase A2: its effect on enzymatic and pathological activitiesCharacterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid
P50
Q28547272-88AB0BA5-CD19-444D-9BEA-D0963F0F68FFQ33905743-BA492565-F8E2-43BE-AB66-53F8C7EFD3A6Q33935302-189A9540-60C6-4C48-B172-90DF698B236EQ34418914-17B59111-BBD7-4755-9718-040EBBC538FFQ34489027-12BA187C-DF12-450F-8DBE-DFB960121A12Q35139724-55565C7E-91C4-49F5-AC6E-D4C331291AFAQ36800479-48C15F9B-4295-4C9D-99EB-06CAD5181C1EQ37389327-BDD46B43-50F2-4A2E-9C9B-8B9F271D0F82Q38381494-DDCDBD01-71C4-4B4F-B4FB-087DAA113316Q38393630-1AF31EF0-2003-4952-8FBE-1C90CB080551Q39293488-855B62E5-D5D5-4CE3-B55F-023515DCFE4BQ41352379-151F8A13-CA2A-4544-9F17-26CCA42E3619Q42520787-2383EECE-4F74-4269-9667-6E9908346F0BQ42929595-8EE1CC45-B780-4DD1-B9D6-0FC6A9C8DF1AQ42984505-E96EF806-2B4F-4026-9D7C-2782B571FBB0Q43011583-5D62D9CD-5DF7-4E28-9D2F-5A80B73216F9Q43280543-172DFD05-1EF9-47DE-9B0F-B69EEA0DF777Q43654236-8A7822CB-5F4F-48F2-8B4F-8FAE9E72475BQ44574681-10DA5FB8-C544-4029-A05C-9E0B3BB23F67Q44698474-5A2445A3-1BA4-4E64-9767-17423222A2C5Q44861858-8E355E11-DD15-41A8-B23B-B24B1130AB82Q46165413-26BB68EC-BC38-4434-91D0-ECC6F0DEADDEQ46515651-A27169ED-4FC2-40CF-8B27-A5A6F02E6361Q46635910-11A4881C-ED91-46F2-B660-E003606F83F3Q46705926-3D81CADC-480B-4519-8607-74E12CF53FDDQ46740834-4040EB23-5FF7-441A-98CB-4C49AB9476F2Q47437104-5CE6E8FF-750B-4779-B10C-9BD75C723FECQ47439196-705F1809-993E-487E-BDE9-CEB4B7DC0CE3Q47984593-ECD1D3EA-9204-4B6C-A77F-ABC1B2B9D7DBQ48968660-0B429D15-2CD6-41D9-9771-F55C5C9C71BEQ52995830-08DE08F0-48D3-46BE-B1D6-37B40D7CAC45Q54454614-E5B5ADA2-1E88-45E4-8E4F-C2A685790586Q54479895-1493FD39-2E3B-4AF1-A1BE-AD8E499F7A65Q54580720-D3F9B43A-331E-4E8E-818F-13E866472B29Q55022280-451CC82E-7889-44AB-B4A1-5E931D1B2118Q57726071-EC2D07E7-98FB-4EBF-8F5F-9A93552E882BQ67963781-80AC720B-D4FB-475B-A0ED-A43388A28C51Q68052486-53E46D5B-E381-4145-9250-47FCE573857CQ68549728-93DC9086-3AA4-4776-B3F5-9F01D7F7E27CQ69174931-148636AA-5BD8-4C24-9A66-96596A16A0AB
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
B S Vishwanath
@ast
B S Vishwanath
@es
Bannikuppe Sannanaik Vishwanath
@en
Bannikuppe Sannanaik Vishwanath
@nl
Bannikuppe Sannanaik Vishwanath
@pl
type
label
B S Vishwanath
@ast
B S Vishwanath
@es
Bannikuppe Sannanaik Vishwanath
@en
Bannikuppe Sannanaik Vishwanath
@nl
Bannikuppe Sannanaik Vishwanath
@pl
altLabel
B S Vishwanath
@en
prefLabel
B S Vishwanath
@ast
B S Vishwanath
@es
Bannikuppe Sannanaik Vishwanath
@en
Bannikuppe Sannanaik Vishwanath
@nl
Bannikuppe Sannanaik Vishwanath
@pl
P31
P496
0000-0003-3284-4163